Deubiquitination of RIPK2 by OTUB2 augments NOD2 signalling and protective effects in intestinal inflammation
Clinical and Translational Medicine · 2024
DOI: 10.1002/ctm2.70038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Xue Du und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Receptor-Interacting Protein Serine-Threonine Kinase 2, Nod2 Signaling Adaptor Protein, Signal Transduction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract, but the molecular mechanisms underlying IBD are incompletely understood. In this study, we explored the role and regulating mechanism of otubain 2 (OTUB2), a deubiquitinating enzyme, in IBD.
Methods
To study the function of OTUB2 in IBD, we generated Otub2 –/– mice and treated them with dextran sulfate sodium (DSS) to induce experimental colitis. Bone marrow transplantation was performed to identify the cell populations that were affected by OTUB2 in colitis. The molecular mechanism of OTUB2 in signal transduction was studied by various biochemical methods.
Results
OTUB2 was highly expressed in colon‐infiltrating macrophages in both humans with IBD and mice with DSS‐induced experimental colitis. Colitis was significantly aggravated in Otub2 –/– mice and bone marrow chimeric mice receiving Otub2 –/– bone marrow. OTUB2‐deficiency impaired the production of cytokines and chemokines in macrophages in response to the NOD2 agonist muramyl dipeptide (MDP). Upon MDP stimulation, OTUB2 promoted NOD2 signaling by stabilizing RIPK2. Mechanistically, OTUB2 inhibited the proteasomal degradation of RIPK2 by removing K48‐linked polyubiquitination on RIPK2, which was mediated by the active C51 residue in OTUB2. In mice, OTUB2 ablation abolished the protective effects of MDP administration in colitis.
Conclusion
This study identified OTUB2 as a novel regulator of intestinal inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou, China.
- Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Hannover Medical School, Institute of Medical Microbiology and Hospital Epidemiology, Hannover, Germany.
ORCID-Profile: Xu Wang
Förderung
- Natural Science Foundation of Zhejiang Province
- National Natural Science Foundation of China
Zitieren
APA
Du, X., Xu, J., Mei, F., Shen, J., Zhou, B., Zhu, Z., Li, Z., Su, X., Li, J., Schlüter, D., Ruan, J., & Wang, X. (2024). Deubiquitination of RIPK2 by OTUB2 augments NOD2 signalling and protective effects in intestinal inflammation. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70038
Vancouver
Du X, Xu J, Mei F, Shen J, Zhou B, Zhu Z, et al. Deubiquitination of RIPK2 by OTUB2 augments NOD2 signalling and protective effects in intestinal inflammation. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.70038
BibTeX
@article{Du2024,
author = {Du, Xue and Xu, Jun and Mei, Fuqi and Shen, Jiangyun and Zhou, Bincheng and Zhu, Zhenhu and Li, Zhongding and Su, Xian and Li, Jianmin and Schlüter, Dirk and Ruan, Jing and Wang, Xu},
title = {Deubiquitination of RIPK2 by OTUB2 augments NOD2 signalling and protective effects in intestinal inflammation},
journal = {Clinical and Translational Medicine},
year = {2024},
doi = {10.1002/ctm2.70038}
}
EUVIMED